Dr YuHong Fu

Dr YuHong Fu, Senior Research Fellow, The University of Sydney.

YuHong holds a MD and a PhD that were granted in 1996 and 2002, respectively. She had early employement as a neurologist (2002 – 2005, China). Driven by her passion to develop efficient cure for neurodegenerative disorders, she has been devoting her career path to neuroscience for the past 16 years. During this time she gained research skills from three prestigious laboratories, each with a distinct strength. These experiences have instrumented her with unique multidisciplinary visions and multiple techniques.

In 2017, her research group was developed with the support of Prof. Halliday. Though impacted by re-direction, she published 14 journal articles (71% as first, equal first, or senior author) In the last 6 years, she and her group have gradually built peer recognition. She co-authored several successful funding grants and contributed to NHMRC as a panel reviewer. Now she is ready to present her research to a better yield and translate their research outcome with clinical promises.

Forefront Group:

  • BMC DAMD Parkinson’s disease Research Group
  • BMC DAMD Multiple System Atrophy Research Group


  • Neuropathology, ,
  • Glia
  • Animal models

Specific Skills:

  • Medical Scientist
  • Histology
  • Small animal surgery
  • Animal models
  • Neuropathology
  • Neuroanatomy
  • Immunohistochemistry
  • Flow cytometry
  • Immunofluorescence imaging
  • Tissue Array
  • Digital spatial profiling
  • WB
  • High resolution imaging

Affiliate Organisations

University of Sydney, Brain and Mind Centre, School of Medical Sciences

Neurodegeneration of interest:

Parkinson’s disease, Dementia with Lewy bodies, Multiple system atrophy, Alzheimer’s disease, Neurological autoimmune diseases, Ageing, Neurodegenerative diseases and associated systemic disorders


  • Michael J. Fox Foundation target engagement Award (2019-2021)-Astroglial contribution to the development of a-synucleinopathy reveals novel therapeutic and monitor approach to Parkinson’s disease (CIB)
  • Michael J. Fox Foundation target engagement Award (2019-2020)-Using digital spatial profiling to screen targetable molecules to halt a-synucleinopathy (CIB)
  • NHMRC (2018-2020)-Nix mediated mitophagy: a new therapeutic approach to Parkinson’s disease (CIC)
  • NHMRC (2018-2019)-Sydney & NHMRC equipment grant to refresh the set-up of state-of-the-art histology facility (CIC)
  • (2018) Early access program grant, nanoString, on-cost for one project with Digital spatial profiling (CIA)
  • Michael J. Fox Foundation target engagement Award (2015-2016)-Understanding LRRK2 S910/S935 phosphorylation is important for the therapeutic LRRK2 inhibitor development (CIB)
  • Michael J. Fox Foundation target engagement Award (2015-2016)- Fluorescence tagging of endogenous LRRK2 to enable in vivo imaging in mice and differentiated human IPS cells (CIB)
  • UNSW (2013)-Goldstar Award for NHMRC project application (CIB)